Home » Stocks » CHGCY

Chugai Pharmaceutical Co., Ltd. (CHGCY)

Stock Price: $19.23 USD -0.30 (-1.54%)
Updated May 11, 2021 3:55 PM EDT - Market closed
Market Cap 60.62B
Revenue (ttm) 776.34B
Net Income (ttm) n/a
Shares Out 3.29B
EPS (ttm) 0.59
PE Ratio 32.62
Forward PE 29.07
Dividend $55.00
Dividend Yield 286.01%
Trading Day May 11
Last Price $19.23
Previous Close $19.53
Change ($) -0.30
Change (%) -1.54%
Day's Open 19.04
Day's Range 18.75 - 19.23
Day's Volume 131,375
52-Week Range 18.24 - 29.32

News

There are no news available yet.

About CHGCY

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, marketing, and distribution of prescription medicines in Japan and internationally. The company's products for oncology primarily include Avastin, Herceptin, Rituxan, Alecensa, Perjeta, Xeloda, Tarceva, Kadcyla, Zelboraf, Neutrogin, Tecentriq, and Gazyva; bone and joint diseases/autoimmune diseases comprise Actemra, Edirol, Suvenyl, and Bonviva; renal diseases consist of Mircera and Oxarol; and other diseases comprise Tamiflu, Cel... [Read more...]

Industry
Drug Manufacturers-General
Founded
1925
CEO
Tatsuro Kosaka
Employees
7,555
Stock Exchange
OTCMKTS
Ticker Symbol
CHGCY
Full Company Profile